Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-26-065925
Filing Date
2026-06-05
Accepted
2026-06-05 17:26:24
Documents
1
Period of Report
2026-06-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9105
  Complete submission text file 0001213900-26-065925.txt   10498
Mailing Address 89 MELROSE DRIVE MISSION VIEJO CA 92692
Business Address
Pham Quang X (Reporting) CIK: 0001405290 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41596 | Film No.: 261070369

Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)